At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMR Alpha Metallurgical Resources Inc
Closed Good Friday 04-17 16:00:00 EDT
124.22
+5.74
+4.84%
盘后124.22
+0.000.00%
18:21 EDT
| High124.94 | Low118.62 | Vol318.15K |
| Open118.67 | D1 Closing118.48 | Amplitude5.34% |
| Mkt Cap1.62B | Tradable Cap1.44B | Total Shares13.05M |
| T/O39.12M | T/O Rate2.75% | Tradable Shares11.56M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
B. Riley Adjusts Alpha Metallurgical Resources' Price Target to $183 From $272, Keeps Buy Rating
MT Newswires Live · 04-11
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire · 04-10
Trump Set to Sign Executive Orders to Boost US Coal
Reuters · 04-08
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
GlobeNewswire · 04-08
Simpson to Outfit AMR IndyCar Safety Team in 2025 Season
Business Wire · 04-03
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results
ACCESS Newswire · 03-31
MicroVision Announces Fourth Quarter and Full Year 2024 Results
ACCESS Newswire · 03-26
Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older
Business Wire · 03-25
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
GlobeNewswire · 03-24
Kudan Integrates Visual SLAM with NVIDIA Isaac Perceptor, Enhancing AMR Capabilities
TIPRANKS · 03-18
bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
PR Newswire · 03-18
If You Invested $1000 in Itron a Decade Ago, This is How Much It'd Be Worth Now
Zacks · 03-13
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire · 03-13
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
GlobeNewswire · 03-11
Undervalued Small Caps With Insider Action To Watch In March 2025
Simply Wall St. · 03-11
Brokers are tipping these super strong ASX 200 growth shares to rise 20%+
MotleyFool · 03-05
B. Riley Cuts Price Target on Alpha Metallurgical Resources to $272 From $327, Keeps Buy Rating
MT Newswires Live · 03-04
Alpha Metallurgical Resources (NYSE:AMR) Sees Stock Fall 12% After US$2 Million Q4 Loss
Simply Wall St. · 03-03
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
GlobeNewswire · 03-03
Alpha Metallurgical Resources Full Year 2024 Earnings: Revenues Disappoint
Simply Wall St. · 03-02
Introduction
Company Name.
Alpha Metallurgical Resources Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Alpha Metallurgical Resources, Inc., a mining company, produces, processes, and sells met and thermal coal in Virginia and West Virginia. The company offers metallurgical coal products. It operates twenty-two active mines and nine coal preparation and load-out facilities. The company was formerly known as Contura Energy, Inc. and changed its name to Alpha Metallurgical Resources, Inc. in February 2021. Alpha Metallurgical Resources, Inc. was incorporated in 2016 and is headquartered in Bristol, Tennessee.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App